Sami-Sabinsa Group to expand its business operations in Japan

Sabinsa Japan Corporation, a division of the Sami-Sabinsa Group, has signed a Memorandum of Understanding (MoU) with the Japan External Trade Organization (JETRO) to support former's expansion in Japan

0
48
Download PDF

New Delhi: Sabinsa Japan Corporation, a division of the Sami-Sabinsa Group, has signed a Memorandum of Understanding (MoU) with the Japan External Trade Organization (JETRO) to support Sabinsa’s expansion in Japan.

The MoU was signed during the 13th India-Japan Annual Summit, held between the Prime Minister of India Mr Narendra Modi and the Prime Minister of Japan Mr Shinzo Abe, on October 29, 2018 in Tokyo.

“As we continue our global expansion, we deeply appreciate the support of the Government of India and the trade development programs of the countries in which we do business, such as JETRO,” said Sabinsa founder, Dr Muhammed Majeed. “Although we have had an office in Japan for some time, the support of the Government of Japan as we continue our investment in that country will allow us to more quickly make our products to enhance human health available on a wider scale to the people of Japan.”

Dr Majeed first set up Sabinsa Corporation in New Jersey, USA in 1988. In 1991, he set up Sami Labs Ltd in Bangalore, which does ground-breaking work in unlocking the mystery of herbs, extracting the goodness and gifting the world with good health, by combining ancient Ayurveda and modern medicine. Its research facility in Bangalore has over 200 scientists involved in specialized work in areas of phytochemistry, organic chemistry, biochemistry, tissue culture and plant biotechnology.

Backed by over 110 international patents, the company’s products include protein, fibres, curcumine, probiotics, sport nutrients, diabetic and metabolism management products, cosmeceuticals which include 50 plus natural beauty care products. It’s  one of the largest manufacturer as well as marketer of herbal extracts, nutritional /dietary supplements and cosmeceuticals across US, Europe, Japan, China, Australia, UAE, South Africa and Malaysia.